Page 83 - Revised Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Revised coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Revised Coverage Today - Breaking & Trending Today

Advance tax collections for corporate tax, income tax turn positive


Advance tax collections for corporate tax, income tax turn positive
March 17, 2021
 
Advance tax collections for both corporate tax and income tax have turned positive at the end of fourth instalment which was to be paid on March 15. Also, shortfall in net direct collection has come down 4 per cent now as against 9 per cent in January and around 13 per cent after payment of third instalment of advance tax on December 15.
Giving updated figure of advance tax collection, a senior Finance Ministry official said that advance tax collections for corporate tax saw an increase of 8.5 per cent on yearly basis. Similarly, for income tax, advance tax collection is now showing an increase of 2.3 per cent. “Overall outlook is positive. Increase in advance tax for advance tax collection implies that corporate earnings have improved significantly,” the official said. ....

Finance Ministry , Indirect Tax Collection , Advance Tax Collections , Corporate Tax , Income Tax , நிதி அமைச்சகம் , நேரடி வரி சேகரிப்பு , பெருநிறுவன வரி , வருமானம் வரி ,

VOLKSWAGEN VORZÜGE : Buy rating from RBC


Message :
Required fields
In his latest research note, analyst Tom Narayan confirms his positive recommendation. The broker RBC is keeping its Buy rating. The target price is revised upwards from EUR 275 to EUR 208.
© MarketScreener with dpa-AFX Analyser 2021
All news about VOLKSWAGEN AG
04:41a ....

Tom Narayan , Volkswagen Ag Stock Exchange , Press Release , Eur Vow3 De0007664039 , டோம் நாராயண் , ப்ரெஸ் வெளியீடு ,

Medtronic: FDA Approves Revised Commercial Labeling For Intellis Platform


Medtronic: FDA Approves Revised Commercial Labeling For Intellis Platform
FRIDLEY (dpa-AFX) - Medtronic plc (MDT) announced the FDA has approved revised commercial labeling for the Intellis Platform with Differential Target Multiplexed programming for the treatment of chronic, intractable back and leg pain. The company noted that the new labeling will include study outcomes from a multicenter randomized control trial reflecting superior back pain relief with Differential Target Multiplexed Spinal Cord Stimulation when compared to conventional Spinal Cord Stimulation.
Charlie Covert, vice president and general manager, Pain Therapies within the Neuromodulation business, which is part of the Neuroscience Portfolio at Medtronic, said: The updated labeling further strengthens the credibility of the outcomes from this therapy, and parallels the profound benefits our clinician partners are seeing with their own patients. ....

Intellis Platform , Differential Target Multiplexed , Spinal Cord , Pain Therapies , Neuroscience Portfolio , முதுகெலும்பு தண்டு , வலி சிகிச்சைகள் , நரம்பியல் போர்ட்‌ஃபோலீயோ ,

百奧泰2020年賣出格樂立20萬支 3個在研產品折戟需警惕研發風險

百奧泰2020年賣出格樂立20萬支 3個在研產品折戟需警惕研發風險
sina.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.tw Daily Mail and Mail on Sunday newspapers.

Research Progress , National Medicare , ஆராய்ச்சி ப்ரோக்ரெஸ் , தேசிய மருத்துவ ,